{
  "abstract": "Management of asymptomatic high-grade carotid stenosis has remained a matter of debate as advances in best medical therapy and revascularization techniques have challenged the relevance of earlier trials favoring carotid endarterectomy.1 2 The Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) evaluated whether carotid revascularization—either percutaneous carotid artery stenting or carotid endarterectomy—provides additional benefit beyond contemporary intensive medical therapy alone.3",
  "authors": [
    {
      "affiliations": [
        "Interventional Neuroradiology/Endovascular Neurosurgery Division Department of Neurology, Neurosurgery and Radiology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA"
      ],
      "name": "Edgar A Samaniego"
    },
    {
      "affiliations": [
        "Novant Hlth Forsyth Radiol Associates, Winston Salem, North Carolina, USA"
      ],
      "name": "Donald V Heck"
    },
    {
      "affiliations": [
        "Department of Neurosurgery, Stony Brook University, Stony Brook, New York, USA",
        "SUNY SB, New York, USA"
      ],
      "name": "David Fiorella"
    },
    {
      "affiliations": [
        "NeuroEndovascular Program, Massachusetts General Hospital, Boston, Massachusetts, USA"
      ],
      "name": "Joshua A Hirsch"
    },
    {
      "affiliations": [
        "Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA"
      ],
      "name": "Michael Chen"
    }
  ],
  "title": "CREST-2: percutaneous carotid stenting plus intensive medical therapy reduces stroke in asymptomatic patients",
  "uid": "47b5cc40-3166-54a7-97eb-e58f684f2f60"
}